RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 75 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,290,207 | +40.6% | 99,900 | +1.1% | 0.00% | +100.0% |
| Q2 2023 | $1,629,212 | -6.1% | 98,800 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $1,735,832 | -39.1% | 97,300 | -0.6% | 0.00% | -50.0% |
| Q4 2022 | $2,850,848 | +29.9% | 97,900 | +9.3% | 0.00% | 0.0% |
| Q3 2022 | $2,195,000 | +534.4% | 89,600 | +7.6% | 0.00% | – |
| Q2 2022 | $346,000 | -64.0% | 83,300 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $960,000 | +23.9% | 83,300 | +7.2% | 0.00% | – |
| Q4 2021 | $775,000 | -23.6% | 77,700 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,015,000 | -31.8% | 77,700 | +2.2% | 0.00% | 0.0% |
| Q2 2021 | $1,488,000 | -11.1% | 76,000 | -3.4% | 0.00% | 0.0% |
| Q1 2021 | $1,674,000 | +2.4% | 78,700 | +43.1% | 0.00% | 0.0% |
| Q4 2020 | $1,635,000 | +37.2% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,192,000 | -1.0% | 55,000 | +1.9% | 0.00% | 0.0% |
| Q2 2020 | $1,204,000 | +32.7% | 54,000 | -9.4% | 0.00% | 0.0% |
| Q1 2020 | $907,000 | -30.8% | 59,600 | +4.4% | 0.00% | 0.0% |
| Q4 2019 | $1,311,000 | +72.5% | 57,100 | +62.2% | 0.00% | 0.0% |
| Q3 2019 | $760,000 | -1.8% | 35,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $774,000 | -9.8% | 35,200 | +12.5% | 0.00% | 0.0% |
| Q1 2019 | $858,000 | +5.7% | 31,300 | +3.6% | 0.00% | 0.0% |
| Q4 2018 | $812,000 | -2.6% | 30,200 | +5.6% | 0.00% | 0.0% |
| Q3 2018 | $834,000 | -6.7% | 28,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $894,000 | – | 28,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |